Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H van der HELM

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
RMD Open|June 7, 2019
Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectivesLeonie E Burgers, Karim Raza, Annette H van der Helm-van Mil
Rheumatology (Oxford, England)|August 7, 2014
Strategies to predict rheumatoid arthritis development in at-risk populationsElizabeth W Karlson, Dirkjan van Schaardenburg, Annette H van der Helm-van Mil
Annals of the Rheumatic Diseases|August 3, 2016
Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysisJ S Dekkers, J W Schoones, T W Huizinga, et al.
Journal of Pediatric Psychology|December 1, 1993
Effects of behavioral psychophysiological treatment on schoolchildren with migraine in a nonclinical setting: predictors and process variablesS O Osterhaus, J Passchier, H van der Helm-Hylkema, et al.
Arthritis Research & Therapy|October 30, 2021
Immunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA statusH Koppejan, M Hameetman, G Beyrend, et al.
Cytometry. Part B, Clinical Cytometry|January 17, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Cytometry. Part B, Clinical Cytometry|January 30, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Journal of Hematology & Oncology|April 17, 2013
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patientsLieke H van der Helm, Ellen R M Scheepers, Nic J G M Veeger, et al.
Arthritis and Rheumatism|February 10, 2011
Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic jointCees M Meeuwisse, Michael P van der Linden, Ton A Rullmann, et al.
Annals of the Rheumatic Diseases|April 16, 2009
Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritisHans Ulrich Scherer, Michael P M van der Linden, Fina A S Kurreeman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
RMD Open|June 7, 2019
Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectivesLeonie E Burgers, Karim Raza, Annette H van der Helm-van Mil
Rheumatology (Oxford, England)|August 7, 2014
Strategies to predict rheumatoid arthritis development in at-risk populationsElizabeth W Karlson, Dirkjan van Schaardenburg, Annette H van der Helm-van Mil
Annals of the Rheumatic Diseases|August 3, 2016
Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysisJ S Dekkers, J W Schoones, T W Huizinga, et al.
Journal of Pediatric Psychology|December 1, 1993
Effects of behavioral psychophysiological treatment on schoolchildren with migraine in a nonclinical setting: predictors and process variablesS O Osterhaus, J Passchier, H van der Helm-Hylkema, et al.
Arthritis Research & Therapy|October 30, 2021
Immunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA statusH Koppejan, M Hameetman, G Beyrend, et al.
Cytometry. Part B, Clinical Cytometry|January 17, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Cytometry. Part B, Clinical Cytometry|January 30, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Journal of Hematology & Oncology|April 17, 2013
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patientsLieke H van der Helm, Ellen R M Scheepers, Nic J G M Veeger, et al.
Arthritis and Rheumatism|February 10, 2011
Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic jointCees M Meeuwisse, Michael P van der Linden, Ton A Rullmann, et al.
Annals of the Rheumatic Diseases|April 16, 2009
Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritisHans Ulrich Scherer, Michael P M van der Linden, Fina A S Kurreeman, et al.
Pageof 2